Article Data

  • Views 527
  • Dowloads 104

Case Reports

Open Access

Angiomyofibroblastoma of the vulva

  • M. Kanda1,*,
  • A. Sonoyama1
  • H. Hirano2
  • T. Kizaki2
  • N. Ohara1

1Department of Obstetrics and Gynecology and 2Department of Pathology, Sanda Municipal Hospital, Sanda (Japan)

DOI: 10.12892/ejgo24082014 Vol.35,Issue 1,January 2014 pp.77-80

Published: 10 January 2014

*Corresponding Author(s): M. Kanda E-mail: kanda_masatoshi@hospital.sanda.hyogo.jp

Abstract

Background: Angiomyofibroblastoma (AMF) is a rare benign mesenchymal neoplasm that arises in the pelviperial region. Case: A patient presented with a painless mass in the right vulva. Under the preoperative diagnosis of Bartholin cyst, she underwent a simple tumor excision. Pathological examination revealed an AMF. Immunohistochemical examination showed that tumor cells were positive for estrogen receptor, progesterone receptor, vimentin, and CD34. She has been with no evidence of local recurrence for ten months after surgery. Conclusion: AMF of the vulva is a distinctive mesenchymal tumor that is curable with a simple excision.


Keywords

Angiomyofibroblastoma; Immunohistochemistry; Vulva.


Cite and Share

M. Kanda,A. Sonoyama,H. Hirano,T. Kizaki,N. Ohara. Angiomyofibroblastoma of the vulva. European Journal of Gynaecological Oncology. 2014. 35(1);77-80.

References

[1] Sims S.M., Stinson K., McLean F.W., Davis J.D., Wilkinson E.J.: “Angiomyofibroblastoma of the vulva: a case report of a pedunculated variant and review of the literature”. J. Low Genit. Tract Dis., 2012, 16, 149.

[2] Hsu I.H., Chang T.C., Wu C.T., Chen R.J., Chow S.N.: “Angiomyofibroblastoma of the vulva”. J. Formos. Med. Assoc., 2004, 103, 467.

[3] Dierickx I., Deraedt K., Poppe W., Verguts J.: “Aggressive angiomyxoma of the vulva: a case report and review of literature”. Arch. Gynecol. Obstet., 2008, 277, 483.

[4] Dahiya K., Jain S., Duhan N., Nanda S., Kundu P.: “Aggressive angiomyxoma of vulva and vagina: a series of three cases and review of literature”. Arch. Gynecol. Obstet., 2011, 283, 1145.

[5] Fletcher C.D.M., Tsang W.Y.W., Fisher C., Lee K.C., Chan J.K.C.: “Angiomyofibroblastoma of the vulva. a benign neoplasm distinct from aggressive angiomyxoma”. Am. J. Surg. Pathol., 1992, 16, 373.

[6] Kim S.W., Lee J.H., Han J.K., Jeon S.: “Angiomyofibroblastoma of the vulva: sonographic and computed tomographic findings with pathologic correlation”. J. Ultrasound Med., 2009, 28, 1417.

[7] Nagai K., Aadachi K., Saito H.: “Huge pedunculated angiomyofibroblastoma of the vulva”. Int .J. Clin. Oncol., 2010, 15, 201.

[8] Barat S., Tirgar-Tabari S., Shafaee S.: “Angiomyofibroblastoma of the vulva”. Arch. Iran. Med., 2008, 11, 224.

[9] Omori M., Toyoda H., Hirai T., Ogino T., Okada S.: “Angiomyofibroblastoma of the vulva: a large pedunculated mass formation”. Acta. Med. Okayama, 2006, 60, 237.

[10] Montella F., Giana M., Vigone A., Surico D., Surico N.: “Angiomyofibroblastoma of the vulva: report of a case”. Eur. J. Gynaecol. Oncol., 2004, 25, 253.

[11] Horiguchi H., Matsui-Horiguchi M., Fujiwara M., Kaketa M., Kawano M., Ohtsubo-Shimoyamada R. et al.: “Angiomyofibroblastoma of the vulva: report of a case with immunohistochemical and molecular analysis”. Int. J. Gynecol. Pathol., 2003, 22, 277.

[12] Nasu K., Fujisawa K., Takai N., Miyakawa I.: “Angiomyofibroblastoma of the vulva”. Int. J. Gynecol. Cancer, 2002, 12, 228.

[13] Kairi-Vassilatou E., Dastamani C., Vouza E., Mavrigiannaki P., Hasiakos D., Kondi-Pafiti A.: “Angiomyofibroblastoma of the vulva: a clinicopathological and immunohistochemical analysis of

a rare benign mesenchymal tumor”. Eur. J. Gynaecol. Oncol., 2011, 32, 353.

[14] Giannella L., Costantini M., Mfuta K., Cavazza A., Cerami L.B., Gardini G. et al.: “Pedunculated angiomyofibroblastoma of the vulva: case report and review of the literature”. Case Report Med., 2011, ID893261.

[15] Ichinokawa Y., Sadamasa H., Hiruma M., Matumoto T., Shinozaki M., Shibuya K. et al.: “Case of aggressive angiomyxoma of the vulva”. J. Dermatol., 2012, 39, 934.

[16] Sun N.X., Li W.: “Aggressive angiomyxoma of the vulva: case report and literature review”. J. Int. Med. Res., 2010, 38, 1547.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top